CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $197,000 | -76.4% | 2,600 | -65.2% | 0.04% | -83.3% |
| Q3 2021 | $835,000 | -27.3% | 7,465 | +5.2% | 0.25% | -23.9% |
| Q2 2021 | $1,149,000 | +237.0% | 7,095 | +153.8% | 0.33% | +184.5% |
| Q1 2021 | $341,000 | -20.3% | 2,795 | 0.0% | 0.12% | -15.9% |
| Q4 2020 | $428,000 | -38.3% | 2,795 | -66.3% | 0.14% | -34.6% |
| Q3 2020 | $694,000 | -54.3% | 8,295 | -59.8% | 0.21% | -51.0% |
| Q2 2020 | $1,517,000 | +246.3% | 20,647 | +99.9% | 0.43% | +169.4% |
| Q1 2020 | $438,000 | +366.0% | 10,330 | +570.8% | 0.16% | +332.4% |
| Q4 2019 | $94,000 | – | 1,540 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |